Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 8/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9584499 | 0.88 | CYP1A2 (0.46) | CYP2D6CYP1A2MAPK1 | |
| SCHEMBL10814219 | 0.88 | CYP1A2 (0.46) | CYP2D6CYP1A2MAPK1CYP3A4FGFR1 | |
| SCHEMBL10816341 | 0.85 | CYP1A2 (0.51) | CYP2D6CYP1A2CYP3A4FGFR1 | |
| SCHEMBL10814386 | 0.84 | P2RY1 (0.46) | CYP2D6CYP3A4FGFR1 | |
| SCHEMBL10817453 | 0.82 | ADORA2A (0.51) | CYP2D6CYP3A4FGFR1 | |
| SCHEMBL10817760 | 0.81 | CYP1A2 (0.48) | CYP2D6CYP1A2CYP3A4FGFR1 | |
| SCHEMBL9583917 | 0.80 | CYP1A2 (0.50) | CYP2D6CYP1A2MAPK1 | |
| SCHEMBL10815175 | 0.79 | PDE3A (0.35) | CYP2D6CYP1A2CYP3A4FGFR1 | |
| SCHEMBL10816711 | 0.77 | CYP1A2 (0.37) | CYP2D6CYP1A2MAPK1CYP3A4 | |
| SCHEMBL10811445 | 0.76 | PDE3A (0.61) | MAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0105135-B1 | SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-03-18 | — | — | EP | disclosed |
| US-4609661-A | HERPES VIRUS | SYNTEX (U.S.A.) INC. (US) | 1986-09-02 | — | — | US | disclosed |
| US-4556659-A | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1985-12-03 | — | — | US | disclosed |
| EP-0105135-A1 | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1984-04-11 | — | — | EP | disclosed |